Viewing Study NCT05639933


Ignite Creation Date: 2025-12-25 @ 3:00 AM
Ignite Modification Date: 2025-12-30 @ 12:24 PM
Study NCT ID: NCT05639933
Status: RECRUITING
Last Update Posted: 2025-07-16
First Post: 2022-11-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors
Sponsor: Hoth Therapeutics, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-07-19
Start Date Type: ACTUAL
Primary Completion Date: 2026-12-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-12-30
Completion Date Type: ESTIMATED
First Submit Date: 2022-11-14
First Submit QC Date: None
Study First Post Date: 2022-12-07
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-07-11
Last Update Post Date: 2025-07-16
Last Update Post Date Type: ACTUAL